These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 29667945)
1. Pulmonary Sarcoidosis Induced by Anti-Tumor Necrosis Factor Therapy: A Paradoxical Effect. Aliel Vigano Pugliesi A; Zerbini Mariano R; Matsunaga De Angelis C; Barros Bertolo M; Alexandre Yazbek M J Clin Rheumatol; 2020 Jan; 26(1):23-24. PubMed ID: 29667945 [No Abstract] [Full Text] [Related]
2. Adalimumab-induced pulmonary sarcoidosis not progressing upon treatment with etanercept. Jung JH; Kim JH; Song GG Z Rheumatol; 2017 May; 76(4):372-374. PubMed ID: 28124746 [TBL] [Abstract][Full Text] [Related]
3. Management with secukinumab of tumour necrosis factor inhibitor-induced pulmonary sarcoidosis-like reaction in a patient with psoriasis. Eichhoff G Clin Exp Dermatol; 2020 Jun; 45(4):455-456. PubMed ID: 31541476 [No Abstract] [Full Text] [Related]
4. Treatment patterns following discontinuation of adalimumab, etanercept, and infliximab in a US managed care sample. Yeaw J; Watson C; Fox KM; Schabert VF; Goodman S; Gandra SR Adv Ther; 2014 Apr; 31(4):410-25. PubMed ID: 24604700 [TBL] [Abstract][Full Text] [Related]
5. Spontaneous resolution of a tumor like pulmonary sarcoidosis. Moatemri Z; Soussi G; Dabboussi S; Mhamdi S; Aichaouia C; Khadraoui M; Cheikh R Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):292-296. PubMed ID: 27758997 [TBL] [Abstract][Full Text] [Related]
6. Successful treatment of ankylosing spondylitis coexisting with pulmonary sarcoidosis by infliximab. Ochi S; Nanki T; Kaneko H; Honne K; Miyazaki Y; Komano Y; Miyasaka N Clin Exp Rheumatol; 2009; 27(4):698-9. PubMed ID: 19772811 [No Abstract] [Full Text] [Related]
7. Hepatosplenic T-Cell Lymphoma Arising in a Patient Treated With Tumor Necrosis Factor-α Inhibitors for Ankylosing Spondylitis. Choi Y; Jeon SY; Yoo WH J Clin Rheumatol; 2019 Dec; 25(8):e134-e135. PubMed ID: 31764502 [No Abstract] [Full Text] [Related]
8. Pulmonary sarcoid-like granulomata in a patient treated for extrapulmonary Hodgkin's disease. van den Berg ; Fickers M; Theunissen P; van Noord JA Respiration; 1997; 64(1):114-7. PubMed ID: 9044487 [TBL] [Abstract][Full Text] [Related]
9. [Pulmonary sarcoidosis developing during treatment with etanercept]. Kerjouan M; Jouneau S; Lena H; Luraine R; Desrues B; Delaval P Rev Mal Respir; 2011 Mar; 28(3):360-4. PubMed ID: 21482342 [TBL] [Abstract][Full Text] [Related]
10. Paradoxical psoriasis following anti-TNF therapy in ankylosing spondylitis: A population-based cohort study. Bae JM; Kwon HS; Kim GM; Park KS; Kim KJ J Allergy Clin Immunol; 2018 Sep; 142(3):1001-1003.e2. PubMed ID: 29859201 [No Abstract] [Full Text] [Related]
11. Pulmonary sarcoidosis. Baughman RP Clin Chest Med; 2004 Sep; 25(3):521-30, vi. PubMed ID: 15331189 [TBL] [Abstract][Full Text] [Related]
12. Adalimumab as a successful alternative for the treatment of infliximab-induced sarcoidosis. Ando T; Kamiya K; Maekawa T; Komine M; Murata S; Ohtsuki M J Dermatol; 2019 Oct; 46(10):e360-e362. PubMed ID: 31017685 [No Abstract] [Full Text] [Related]
13. Reasons for Discontinuation and Adverse Effects of TNFα Inhibitors in a Cohort of Patients With Rheumatoid Arthritis and Ankylosing Spondylitis. García-Lagunar MH; Gutiérrez-Cívicos MR; García-Simón MS; Conesa-Zamora P; Jimenez-Santos E; Cano-Vivar P; García-Márquez A; Muñoz-García I; Viney AC Ann Pharmacother; 2017 May; 51(5):388-393. PubMed ID: 27920336 [TBL] [Abstract][Full Text] [Related]
14. Etanercept-induced Crohn's disease in ankylosing spondylitis: a case report and review of the literature. Tolu S; Rezvani A; Hindioglu N; Calkin Korkmaz M Rheumatol Int; 2018 Nov; 38(11):2157-2162. PubMed ID: 30293157 [TBL] [Abstract][Full Text] [Related]
15. Coexistent pulmonary cryptococcal infection and pulmonary sarcoidosis: a case report and literature review. Zhou B; She J; Yang L; Zhu B J Int Med Res; 2020 Feb; 48(2):300060520903870. PubMed ID: 32070156 [No Abstract] [Full Text] [Related]
16. TNF-α inhibitor-induced paradoxical psoriasis and erythema nodosum in a patient with ankylosing spondylitis. Watabe D; Amano H Eur J Dermatol; 2021 Jun; 31(3):412-413. PubMed ID: 34309528 [No Abstract] [Full Text] [Related]
17. The Safety Profile of Tumor Necrosis Factor Inhibitors in Ankylosing Spondylitis: Are TNF Inhibitors Safer Than We Thought? Wroński J; Fiedor P J Clin Pharmacol; 2019 Apr; 59(4):445-462. PubMed ID: 30476367 [TBL] [Abstract][Full Text] [Related]
18. Henoch-Schönlein purpura during anti-TNFα therapy: a fortuitous event or an indication to stop therapy? Pinheiro RR; Lencastre A Eur J Dermatol; 2017 Jun; 27(3):304-305. PubMed ID: 28468732 [No Abstract] [Full Text] [Related]
19. Pulmonary Sarcoidosis Presenting with Miliary Opacities. Taki M; Ikegami N; Konishi C; Nakao S; Funazou T; Ariyasu R; Yoshida M; Nakagawa K; Morita K; Hee Hwang M; Yoshimura C; Wakayama T; Nishizaka Y Intern Med; 2015; 54(19):2483-6. PubMed ID: 26424308 [TBL] [Abstract][Full Text] [Related]
20. Antinuclear Antibodies and Lupus-like Manifestations in Rheumatoid Arthritis and Ankylosing Spondylitis Patients at 4 Months' Follow-up After Treatment with Infliximab and Etanercept. Aghdashi MA; Khadir M; Dinparasti-Saleh R Curr Rheumatol Rev; 2020; 16(1):61-66. PubMed ID: 31057111 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]